Siemens Healthineers Plans Exit From American Oncology Institute in INR 1,500–2,000 Cr Deal

The deal is being advised by investment firm Alvarez & Marsal, and several private equity funds have been approached as potential buyers.

Siemens Healthineers is planning to exit its India-based cancer care chain American Oncology Institute in a transaction valued at around ₹1,500–2,000 crore, according to people familiar with the matter.

The deal is being advised by investment firm Alvarez & Marsal, and several private equity funds have been approached as potential buyers. Listed oncology chain Healthcare Global Enterprises, backed by KKR, is also among the bidders being considered, sources said.

American Oncology Institute operates 16 hospitals across India and one facility in Sri Lanka, focusing on comprehensive cancer care services. The proposed divestment is part of Siemens Healthineers’ broader strategic review of its global healthcare portfolio.

The development comes at a time when India’s cancer care sector is witnessing steady expansion, driven by rising incidence of cancer, increased diagnostic awareness, and growing demand for advanced treatment infrastructure. The sector has also seen heightened interest from private equity investors and hospital chains seeking to expand oncology networks.

If completed, the transaction would mark Siemens Healthineers’ exit from direct ownership of a multi-country oncology hospital chain, while potentially reshaping the competitive landscape of organized cancer care in India.

The process is still in early stages, and the final valuation and ownership structure may evolve depending on negotiations with interested parties.

Stay tuned for more such updates on Digital Health News